KZIA vs GILD: Which Stock is Better?
Side-by-side comparison of Kazia Therapeutics Ltd and Gilead Sciences Inc in 2026
KZIA
Kazia Therapeutics Ltd
$11.22
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | KZIA | GILD | Winner |
|---|---|---|---|
| Market Cap | $124.78M | $171.97B | GILD |
| P/E Ratio | N/A | 20.44 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 3.1% | 0.0% | KZIA |
| Gross Margin | 100.0% | 78.8% | KZIA |
Analyze KZIA
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KZIA or GILD a better investment?
Comparing KZIA and GILD: Kazia Therapeutics Ltd has a market cap of $124.78M while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KZIA and GILD?
KZIA (Kazia Therapeutics Ltd) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KZIA or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KZIA or GILD?
KZIA has higher revenue growth at 3.1% vs 0.0% for GILD.
Which company is more profitable: KZIA or GILD?
Kazia Therapeutics Ltd (KZIA) has higher gross margins at 100.0% compared to 78.8% for GILD.
Which is the larger company: KZIA or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $124.78M for KZIA.
Should I buy KZIA or GILD in 2026?
Both KZIA and GILD have investment merit. KZIA trades at $11.22 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KZIA and GILD stock?
Key differences: Market Cap ($124.78M vs $171.97B), P/E Ratio (N/A vs 20.4x), Revenue Growth (3.1% vs 0.0%), Gross Margin (100.0% vs 78.8%).